ÀÌÁßÁ÷¼±ÇüÀÌ¿ÂÆ®·¦(Velos ProTM)À» ÀÌ¿ëÇÑ ´ë»ç»ê¹°¿¡ ´ëÇÑ Á¤·® ºÐ¼®
 
 

UV Quantitation of Dextrophan and 3-Methoxymorphinan
»ýü ¹Û¿¡¼­ ¹è¾çµÈ »ùÇÿ¡¼­ÀÇ Dextrophan°ú 3-MethoxymorphinanÀÇ ³óµµ´Â »ùÇÃÀ» ¼¼ ¹ø¾¿ ¹Ýº¹ ÁÖÀÔÇÏ´Â °Í°ú Dextromethorphan ³óµµ¿¡ µû¸¥ UV °Ë·® Ç¥ÁØ °î¼±À¸·Î Á¤·®ºÐ¼®À» ½ÇÇàÇß´Ù. ±× °á°ú DextrophanÀº 1,852ng/ml, 3-MethoxymorphinanÀº 1,484ng/mlÀ¸·Î È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù.

Mass Spectrometer Quantitation-Flexibility in Selecting Transitions
È¥ÇÕ¹°¿¡¼­ÀÇ ´ë»ç»ê¹°¿¡ ´ëÇÑ Á¤È®ÇÑ Á¤·®ºÐ¼®Àº Full Scan MS/MS¸¦ ÅëÇؼ­ ÇÒ ¼ö ÀÖ´Ù. º» ¿¬±¸¿¡¼­ »ç¿ëÇÑ Velos ProTM ÀÌÁß Á÷¼±Çü ÀÌ¿ÂÆ®·¦(Dual-Pressure Linear Ion Trap)Àº HCD¿Í CID Fragmentation MechanismÀ» µÑ ´Ù ±¸ÇöÇÒ ¼ö ÀÖ¾î ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î º¸´Ù ÁÁÀº °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ´Ù. Figure5´Â DextrophanÀÇ CIDÀÇ ÃÖÀûÈ­µÈ Fragmentation°ú HCD Fragmentation PatternÀ» ºñ±³Çß´Ù. CID ½ºÆåÆ®·³¿¡¼­ °¡Àå °¨µµ°¡ ÁÁÀº Peak´Â HCD ½ºÆåÆ®·³À¸·ÎºÎÅÍ ¾òÀº °¡Àå °¨µµ ÁÁÀº Peakº¸´Ù µÎ ¹è ÀÌ»ó ÁÁ¾Ò´Ù. ±× °á°ú, CID´Â DextrophanÀ» Á¤·® ºÐ¼®Çϴµ¥ ¼±ÅÃÇÏ¿´´Ù. 3-MethoxymorphinanÀº HCD¸¦ ÀÌ¿ëÇÒ °æ¿ì, Unique Fragment¸¦ °ËÃâÇÒ ¼ö À־ HCD·Î Á¤·®ºÐ¼®À» Çß´Ù. HCD¿Í CID Fragmentation Spectra´Â µ¿ÀÏÇÑ Run¿¡¼­ ȹµæµÇ¾ú±â ¶§¹®¿¡, Á¤·®¿¡ »ç¿ëÇÑ Fragment IonÀ̳ª Á¤·® ÇÏ°íÀÚ ÇÏ´Â TransitionÀÇ ¼±ÅÃÀº °á°ú¸¦ ReviewÇÏ´Â °úÁ¤¿¡¼­ ¼±ÅõǾîÁö°í, ¾î¶°ÇÑ ½Ã·áÀÇ ÀçÁÖÀÔÀ̳ª ½ÇÇèÀÌ ¿ä±¸µÇ¾îÁöÁö ¾Ê´Â´Ù.


Figure 5. Fragmentation spectra of dextrorphan using CID and HCD

Mass Spectrometer Quantitation-Plasma Samples
»ýü ¹Û¿¡¼­ Microsomes¹è¾çÀÇ Á¤·®Àº ÇöóÁ ¾È¿¡ ÀÖ´Â Dextrophan°ú 3-MethoxymorphinanÀÇ ÀÕµû¸¥ Á¤·®ºÐ¼®À» À§ÇØ Ç¥ÁØ ¹°Áú·Î »ç¿ëµÇ¾ú´Ù. 18 PointsÀÇ °Ë·® Ç¥ÁØ °î¼±Àº DextrophanÀÇ °æ¿ì 0.137¿¡¼­ 1852ng/ml, 3-Methoxymorphinan´Â 0.110¿¡¼­ 1484ng/ml ¹üÀ§·Î Quenched Microsomal Matrix¿Í ÇÔ²² ³óµµ º°·Î Èñ¼®ÇÏ¿© ÁغñÇÏ¿´´Ù.
LC-MS »ùÇÃÀÇ Matrix´Â ºÐ¼®¹°ÁúÀÇ Peak °¨µµ¿¡ ´«¿¡ ¶ç°Ô ¿µÇâÀ» ÁÙ ¼ö ÀÖ°í, Ç¥Áؽ÷á´Â Blank Plasma Extract¿Í 1:1·Î È¥ÇÕÇؼ­ ¸ðµç »ùÇÃÀº µ¿ÀÏÇÑ Matrix¸¦ °¡Áö°Ô Çß´Ù. 12°³ÀÇ ³óµµº° Ç÷Àå »ùÇÃÀº 2¿¡¼­ 500ng/ml(Dextrophan)°ú 2.5¿¡¼­ 800ng/ml(3-Methoxymorphinan)ÀÇ ³óµµ ¹üÀ§·Î Á¦Á¶ÇÏ¿´´Ù. ÀÌ·¯ÇÑ »ùÇÃÀº Microsomal Blank Matrix¿Í CAN ħÀü¿¡ ÀÇÇØ ÁغñµÇ¾ú´Ù. °Ë·® Ç¥ÁØ °î¼±Àº µ¿ÀÏÇÑ ¸ÅÆ®¸¯½º Á¶°Ç¿¡¼­ ºÐ¼®Çϱâ À§ÇØ ÇöóÁ »óû¾×¿¡ Blank Microsomal MatrixÀ» 1:1·Î È¥ÇÕÇؼ­ ½ÇÇèÇß´Ù.

Quantitative Results for Dextrophan and 3-Methoxymorphinan
°Ë·® Ç¥ÁØ°î¼±ÀÇ ÇÑ ¿¹·Î Figure6¿¡¼­ DextrophanÀ» º¸¿©ÁØ´Ù. ¡¾20%ÀÌ»ó Â÷ÀÌ ³ª´Â °ÍÀº ¹èÁ¦½ÃÅ°°í, °Ë·® °î¼±¿¡ »ç¿ëµÈ Dextrophan°ú 3-Methoxymorphinan Æ÷ÀÎÆ®´Â °¡Àå °£´ÜÇÑ ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ» Àû¿ëÇÏ¿© °Ë·® Ç¥ÁØ °î¼±À» ÀÛ¼ºÇÏ¿´´Ù. ½ºÆÄÀÌÅ©µÈ ÇöóÁ »ùÇÃÀº µ¿ÀÏÇÑ ¸ÅÆ®¸¯½º¿¡¼­ ³óµµº°·Î °Ë·® Ç¥ÁØ °î¼±À» ¸¸µé°í Á¤·® ºÐ¼®ÇÏ¿´´Ù. 12°³ÀÇ »ùÇÃÀº 2¹ø ¹Ýº¹ ½ÇÇèÇÏ¿´À¸¸ç, Table 2¿¡ Æò±Õ°á°ú¸¦ Á¤¸®ÇÏ¿´´Ù. Dextrophan Á¤·®¿¡ ÀÖ¾î 9¹ø »ùÇðú 12¹ø »ùÇÃÀ» Á¦¿ÜÇÏ°í´Â ¸ðµÎ ½ÇÁ¦ °ªÀÇ 20% ¹üÀ§ ³»¿¡¼­ ÃøÁ¤µÇ¾ú´Ù.


Figure 6. Quantitation of dextrorphan by SRM (258 ¡æ201, CID)

Table 2. Quantitation results for spiked plasma samples quantified by MS based on standards prepared by UV-MS correlation


1All values are n=2, except sample #7 where only
one data point was available.

DextrorphanÀÇ Desmethyl MetaboliteÀÇ Á¤·® ºÐ¼®Àº UV-MS¸¦ °ÅÃÄ Velos ProTM ÀÌÁß Á÷¼±Çü ÀÌ¿Â Æ®·¦¿¡¼­ ´ÙÁß Fragmentation ¸ðµå¸¦ ÀÌ¿ëÇÏ¿© LC-MS °Ë·® Ç¥ÁØ °î¼±°ú ÇÔ²² ÀÌÁß ÇöóÁ Microsomal Matrix¿¡ ´õÇÏ¿© ¼º°øÀûÀ¸·Î ´Þ¼ºÇÏ¿´´Ù. ÀÌ ¹æ¹ýÀº ¡¾20%¹üÀ§¿¡¼­ 2°³ÀÇ ½Ã·á¸¦ Á¦¿ÜÇÏ°í´Â ´ëºÎºÐ »ùÇÃÀÌ Çã¿ëµÇ´Â Á¤È®µµ¸¦ Á¦°øÇÏ¿´´Ù.

Parent¸¦ ±â¹ÝÀ¸·Î ÇÑ ´ë»ç»ê¹°ÀÇ UV Á¤·®ºÐ¼®Àº ´ë»çÀÛ¿ëÀÌ ÀϾ ¹°ÁúÀÌ ´«¿¡ ¶ç°Ô ±× µÚ·Î ¸ô Èí±¤ °è¼ö°¡ ¹Ù²îÁö ¾Ê±â ¶§¹®¿¡ °¡´ÉÇÏ´Ù.
ÀÌ¿Â Æ®·¦ Áú·®ºÐ¼®±â¸¦ ÀÌ¿ëÇÑ È¥ÇÕ »ùÇÃÀÇ Á¤·®ºÐ¼®Àº ³ÐÀº ³óµµ ¹üÀ§¿¡¼­ »ç¿ëÀÌ °¡´ÉÇÔÀ» º¸¿©ÁÖ¾ú´Ù.
Velos ProTM ÀÌÁß Á÷¼±Çü ÀÌ¿ÂÆ®·¦Àº ´ÙÁß Fragmentation(CID¿Í HCD)¹æ¹ýÀ» °âºñÇÑ Áú·®ºÐ¼®±â·Î ´ë»ç»ê¹°ÀÇ ¸í¹éÇÑ ±¸Á¶¸¦ ±Ô¸íÇϴµ¥ Æ÷°ýÀûÀÎ FragmentationÀ¸·Î ÀÌ·ç¾îÁø ¿ì¼öÇÑ MSn Á¤º¸¸¦ Á¦°øÇÑ´Ù. °Ô´Ù°¡, ´ÙÁß Fragmentation¹æ¹ýÀº ½Ã·áÀÇ Ãß°¡ÀûÀÎ ÀçÁÖÀÔ¾øÀÌ µ¥ÀÌÅ͸¦ ReviewÇÏ´Â µ¿¾È ÃÖÀûÈ­µÈ ¼±Åüº°ú °¨µµ·Î Á¤·®ÇÏ°íÀÚ ÇÏ´Â TransitionÀ» ¿©·¯ °³ Á¦°øÇÒ ¼ö Àֱ⿡ ±â±âÀûÀÎ Á¤·®¼ºÀÌ ´õ¿í Çâ»óµÇ¾úÀ½À» º¸¿©ÁØ´Ù.
Nominal Mass MSnÀ¸·ÎºÎÅÍ ´ë»ç»ê¹°ÀÇ ±¸Á¶¸¦ ±Ô¸íÇÏ´Â °ÍÀº Mass Frontier 7.0 ¼ÒÇÁÆ®¿þ¾î¸¦ »ç¿ëÇÏ¸é ºü¸¥ ½Ã°£ ³» ¼Õ½±°Ô ºÐ¼®ÇÒ ¼ö ÀÖ´Ù.